Literature DB >> 23338482

Wound complications after inguinal lymph node dissection for melanoma: is ACS NSQIP adequate?

Carly E Glarner1, David Y Greenblatt, Robert J Rettammel, Heather B Neuman, Sharon M Weber.   

Abstract

BACKGROUND: In the treatment of melanoma, inguinal lymph node dissection (ILND) is the standard of care for palpable or biopsy-proven lymph node metastases. Wound complications occur frequently after ILND. In the current study, the multicenter American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) was utilized to examine the frequency and predictors of wound complications after ILND.
METHODS: Patients with cutaneous melanoma who underwent superficial and superficial with deep ILND from 2005-2010 were selected from the ACS NSQIP database. Standard ACS NSQIP 30-day outcome variables for wound occurrences-superficial surgical site infection (SSI), deep SSI, organ space SSI, and disruption-were defined as wound complications.
RESULTS: Of 281 total patients, only 14 % of patients had wound complications, a rate much lower than those reported in previous single institution studies. In a multivariable model, superficial with deep ILND, obesity, and diabetes were significantly associated with wound complications. There was no difference in the rate of reoperation in patients with and without wound complications.
CONCLUSIONS: ACS NSQIP appears to markedly underreport the actual incidence of wound complications after ILND. This may reflect the program's narrow definition of wound occurrences, which does not include seroma, hematoma, lymph leak, and skin necrosis. Future iterations of the ACS NSQIP for Oncology and procedure-specific modules should expand the definition of wound occurrences to incorporate these clinically relevant complications.

Entities:  

Mesh:

Year:  2013        PMID: 23338482      PMCID: PMC3657320          DOI: 10.1245/s10434-012-2856-7

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  11 in total

1.  Prognosis and surgical management of patients with palpable inguinal lymph node metastases from melanoma.

Authors:  T M Hughes; R P A'Hern; J M Thomas
Journal:  Br J Surg       Date:  2000-07       Impact factor: 6.939

2.  Radical lymph node dissection for melanoma.

Authors:  Jonathan W Serpell; Peter W G Carne; Michael Bailey
Journal:  ANZ J Surg       Date:  2003-05       Impact factor: 1.872

3.  Prospective assessment of postoperative complications and associated costs following inguinal lymph node dissection (ILND) in melanoma patients.

Authors:  Sharon B Chang; Robert L Askew; Yan Xing; Storm Weaver; Jeffrey E Gershenwald; Jeffrey E Lee; Richard Royal; Anthony Lucci; Merrick I Ross; Janice N Cormier
Journal:  Ann Surg Oncol       Date:  2010-03-25       Impact factor: 5.344

4.  Morbidity after inguinal sentinel lymph node biopsy and completion lymph node dissection in patients with cutaneous melanoma.

Authors:  M de Vries; W G Vonkeman; R J van Ginkel; H J Hoekstra
Journal:  Eur J Surg Oncol       Date:  2006-06-27       Impact factor: 4.424

5.  Complications and local recurrence following lymphadenectomy.

Authors:  J H Shaw; E M Rumball
Journal:  Br J Surg       Date:  1990-07       Impact factor: 6.939

6.  Morbidity and recurrence after completion lymph node dissection following sentinel lymph node biopsy in cutaneous malignant melanoma.

Authors:  Merlin M Guggenheim; Urs Hug; Florian J Jung; Valentin Rousson; Matthias C Aust; Maurizio Calcagni; Walter Künzi; Pietro Giovanoli
Journal:  Ann Surg       Date:  2008-04       Impact factor: 12.969

7.  Therapeutic groin dissection for melanoma: risk factors for short term morbidity.

Authors:  H P A M Poos; S Kruijff; E Bastiaannet; R J van Ginkel; H J Hoekstra
Journal:  Eur J Surg Oncol       Date:  2008-12-02       Impact factor: 4.424

8.  Prognostic factors in patients with melanoma metastatic to axillary or inguinal lymph nodes. A multivariate analysis.

Authors:  D G Coit; A Rogatko; M F Brennan
Journal:  Ann Surg       Date:  1991-11       Impact factor: 12.969

9.  Inguinal node dissection for melanoma in the era of sentinel lymph node biopsy.

Authors:  Michael S Sabel; Kent A Griffith; Alisha Arora; Josef Shargorodsky; Dan G Blazer; Riley Rees; Sandra L Wong; Vincent M Cimmino; Alfred E Chang
Journal:  Surgery       Date:  2007-06       Impact factor: 3.982

10.  Operative morbidity and risk factor assessment in melanoma patients undergoing inguinal lymph node dissection.

Authors:  P Beitsch; C Balch
Journal:  Am J Surg       Date:  1992-11       Impact factor: 2.565

View more
  13 in total

Review 1.  Perioperative Outcomes of Melanoma Patients Undergoing Surgery After Receiving Immunotherapy or Targeted Therapy.

Authors:  James Sun; Dennis A Kirichenko; Joyce L Chung; Michael J Carr; Zeynep Eroglu; Nikhil I Khushalani; Joseph Markowitz; Jane L Messina; Vernon K Sondak; Jonathan S Zager; Sephalie Y Patel
Journal:  World J Surg       Date:  2020-04       Impact factor: 3.352

2.  Is American College of Surgeons NSQIP organ space infection a surrogate for pancreatic fistula?

Authors:  Janak Atul Parikh; Joal D Beane; E Molly Kilbane; Daniel P Milgrom; Henry A Pitt
Journal:  J Am Coll Surg       Date:  2014-09-03       Impact factor: 6.113

3.  Significance of diabetes on morbidity and mortality following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.

Authors:  Reese W Randle; Shuja Ahmed; Edward A Levine; Nora F Fino; Katrina R Swett; John H Stewart; Perry Shen; Konstantinos I Votanopoulos
Journal:  J Surg Oncol       Date:  2014-12-29       Impact factor: 3.454

4.  Safety of excisional inguinal lymph node biopsies performed for research purposes in HIV-1-infected women and men.

Authors:  Amie L Meditz; Elizabeth Connick; Martin McCarter
Journal:  Surg Infect (Larchmt)       Date:  2014-05-09       Impact factor: 2.150

5.  Optimizing risk-adjusted outcome measures: a moving target. Invited commentary on: Variability of NSQIP assessed surgical quality based on age and disease process.

Authors:  Marquita R Decker; David Y Greenblatt
Journal:  J Surg Res       Date:  2013-02-21       Impact factor: 2.192

Review 6.  Scoping Review of the National Surgical Quality Improvement Program in Plastic Surgery Research.

Authors:  Haley F M Augustine; Jiayi Hu; Zainab Najarali; Matthew McRae
Journal:  Plast Surg (Oakv)       Date:  2018-10-21       Impact factor: 0.947

7.  Body mass index is not a clinically meaningful predictor of patient reported outcomes of primary hip replacement surgery: prospective cohort study.

Authors:  A Judge; R N Batra; G E Thomas; D Beard; M K Javaid; D W Murray; P A Dieppe; K E Dreinhoefer; K Peter-Guenther; R Field; C Cooper; N K Arden
Journal:  Osteoarthritis Cartilage       Date:  2014-01-11       Impact factor: 6.576

8.  Risk Factors for Positive Deep Pelvic Nodal Involvement in Patients with Palpable Groin Melanoma Metastases: Can the Extent of Surgery be Safely Minimized? : A Retrospective, Multicenter Cohort Study.

Authors:  C M C Oude Ophuis; A C J van Akkooi; H J Hoekstra; J J Bonenkamp; J van Wissen; M G Niebling; J H W de Wilt; B van der Hiel; B van de Wiel; S Koljenović; D J Grünhagen; C Verhoef
Journal:  Ann Surg Oncol       Date:  2015-05-27       Impact factor: 5.344

9.  Reducing morbidity with surgical adhesives following inguinal lymph node dissections for the treatment of malignant skin tumors.

Authors:  Peter L Stollwerck; Dominik Schlarb; Nicole Münstermann; Sebastian Stenske; Christoph Kruess; Gerhard Brodner; Björn Dirk Krapohl; Albrecht F Krause-Bergmann
Journal:  GMS Interdiscip Plast Reconstr Surg DGPW       Date:  2016-01-20

10.  Morbidity After Inguinal Lymph Node Dissections: It Is Time for a Change.

Authors:  Marloes Faut; Rianne M Heidema; Harald J Hoekstra; Robert J van Ginkel; S Lukas B Been; Schelto Kruijff; Barbara L van Leeuwen
Journal:  Ann Surg Oncol       Date:  2016-08-12       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.